5 Stocks Congress Quietly Bought in Q3—Should You Follow?

Core Insights - Lawmakers' stock trading raises public frustration due to lack of transparency in reporting financial transactions, with a 45-day window for disclosures [1] Group 1: UnitedHealth Group (UNH) - UnitedHealth Group is among the most frequently bought stocks by Congress in Q3 2025, with nine purchases by five members [3] - Notable buyers include Rep. Marjorie Taylor Greene and others, citing deep value and strong cash flow outlook despite current headwinds [4] - Institutional buying is increasing, and analyst sentiment is shifting towards upgrades, indicating reliable capital return [5] Group 2: JPMorgan Chase (JPM) - JPMorgan Chase saw significant buying activity in Q3, with two members making seven purchases, primarily by Rep. Ro Khanna [7] - Reasons for buying include growth trajectory, cash flow, and reliable capital return, supported by strong analyst coverage and sentiment [8] - The stock is considered fairly valued, with potential for a 20% upside based on current trends [9] Group 3: Uber Technologies (UBER) - Four members of Congress purchased Uber in six transactions, indicating interest in its improving cash flow and aggressive share buyback strategy [12] - Analyst trends are strong, with increased coverage and a potential 20% price increase by year-end [13] Group 4: Advanced Micro Devices (AMD) - AMD has broad-based support from Congress, with purchases from multiple members, positioning it well for the AI revolution [15] - Upcoming product launches and significant agreements, such as with OpenAI, are expected to drive revenue and stock price increases [16] Group 5: Palantir Technologies (PLTR) - Palantir was bought five times by three Congress members, indicating bipartisan interest in its AI data platform for government applications [18] - Reasons for buying include increasing revenue and strong earnings quality, with analysts expecting a 50% price increase at the high end of the range [19]